Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: Research tools and potential therapeutic agents-Reference-Cited by-同舟云学术

Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: Research tools and potential therapeutic agents

Published:2003-06 Issue:6 Volume:73 Page:663-678
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Zaveri Nurulain

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference114 articles.

1. Adam, G., Cesura, A.M., Galley, G., Jenck, F., Monsama, F., Rover, S., Wichmann, J., 1998. New 8-substituted 1,3,8-triazaspiro[4,5]decan-4-one derivatives. European Patent. EP 0856514. Hoffmann-La Roche.

2. Adam, G., Dautzenberg, F.M., Kolczewski, S., Rover, S., Wichmann, J., 2000a. Spiro[piperidine-4,1′-pyrrolo[3,4-C]pyrrole] derivatives. United States Patent. US 6075034. Hoffmann-La Roche, Nutley, N.J.

3. Adam, G., Cesura, A.M., Jenck, F., Kolczewski, S., Rover, S., Wichmann, J., 2000b. Diaza-spiro[3,5] nonane derivatives. United States Patent. US 6113527. Hoffmann-La Roche, Nutley, N.J.

4. Adam, G., Cesura, A.M., Galley, C., Jenck, F., Rover, S., Wichmann, J., 2000c. Piperidine derivatives. United States Patent. US 6166209. Hoffmann-La Roche, Nutley, N.J.

5. Structure-activity studies on nociceptin analogues: ORL1 receptor binding and biological activity of cyclic disulfide-containing analogues of nociceptin peptides;Ambo;Journal of Medicinal Chemistry,2001

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse maternal environment alters Oprl1 variant expression in mouse hippocampus;The Anatomical Record;2022-08-19

2. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors;British Journal of Pharmacology;2021-09-16

3. The Role of Nociceptin in Opioid Regulation of Brain Functions;Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry;2021-07

4. Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development;Chemistry & Biodiversity;2020-12-22

5. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists;Science Signaling;2019-03-26